Selenium (selenomethionine vs selenite) and healthy aging

What 2 graded rows on selenium (selenomethionine vs selenite) agree on for healthy aging, and where they differ. Counted side by side, never averaged.

What the rows agree on

Each block and row is one graded row from the Selenium (selenomethionine vs selenite) page, with its PubMed record.

Your question

Supplement
Selenium (selenomethionine vs selenite) Choose another

Selenium (selenomethionine vs selenite) and healthy aging

2 rows · 62,765 people

They agree: both rows found no difference.

No difference
Improved
Each block is one evidence row, sized by how many people it enrolled, with its grade inside.
  • No effect× 2
Rows
2
Trials
2
At least: a review without a trial count
People
62,765
Pooled reviews may count some twice

What the rows share

From the rows

Every row is graded No effect, our grade for adequately powered trials that found no effect.

The rows run from 27,232 to 35,533 people, published from 2009 to 2018: 1 pooled review and 1 single study.

The rows

2 no difference
  1. No effectSELECT trial primary end point (men 50+) · No difference

    RCT · n 35,533 · 2009 · Relatively healthy men aged 50+ (African American) or 55+ in the US, Canada and Puerto Rico

    200 microg/day, alone or with vitamin E · Median follow-up 5.46 years

    Selenium did not lower prostate cancer risk (HR 1.04; 99% CI 0.87-1.24) or any other prespecified cancer end point. Type 2 diabetes was non-significantly more common with selenium (RR 1.07; 99% CI 0.94-1.22).

    Row on the Selenium (selenomethionine vs selenite) page · PubMed 19066370 (opens PubMed)

  2. No effectLong-term prevention end points (10 placebo-controlled trials) · No difference

    Systematic review · n 27,232 · 2018 · Participants in 10 randomized trials of selenium vs placebo for cancer prevention

    Varied across trials · Varied across trials

    In low-risk-of-bias trials, selenium did not change overall cancer incidence (RR 1.01; 95% CI 0.93 to 1.10; high certainty) or cancer deaths, nor colorectal, lung, bladder or prostate cancer. Low-bias trials suggested a higher melanoma risk.

    Row on the Selenium (selenomethionine vs selenite) page · PubMed 29376219 (opens PubMed)

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.